… In conclusion, corticosteroid therapy is of little benefit in severe and fulminant … that corticosteroid
therapy could avoid LT in severe and fulminant hepatitis in a setting of autoimmune liver …

… Budesonide is presently receiving considerable attention as an alternative to prednisone
or prednisolone in the treatment of autoimmune hepatitis. First reports were somewhat …

… Acute severe presentations of autoimmune hepatitis (AIH) represent a challenge for the …
the initiation of corticosteroids, which can be lifesaving. However, their use in this setting …

… A recent retrospective study from India suggested that use of corticosteroids for acute-on-chronic
liver failure (ACLF) with AIH as an acute insult was significantly associated with a …

… of AS-AIH and early corticosteroid therapy may prevent the need for liver transplantation (LT). …
with AS-AIH presenting to our institution with particular focus on the role of corticosteroids. …

Autoimmune hepatitis (AIH) is an immunoinflammatory chronic liver disease with dynamic
and rather heterogeneous disease manifestations. A trend of increasing prevalence of AIH …

… autoimmune hepatitis (AIH) that is indicated for corticosteroid … for other causes of liver
disease, especially NASH which … Thereafter, if such patients have AIH features, corticosteroid …

… In this study, the use of corticosteroids was also not randomized and unfortunately no
detailed information on the F-AIH group was provided. Overall, the reported response to …

… Corticosteroids remain the cornerstone treatment of AIH as remission rates approach 60–80…
that the usefulness of this treatment extends to this scenario, in which corticosteroids were …

… Core tip: The first part of this review summarizes the standard therapeutic approach for
autoimmune hepatitis (steroids and azathioprine) and the evidence on which it is based. The …